Key Developments For Dialysis Corporation of America
Dialysis Corporation of America (DCAI.O) (Consolidated Issue listed on NASDAQ Global Market)
Dialysis Corporation of America Announces Share Repurchase Program
Dialysis Corporation of America announced that its Board of Directors has approved a stock repurchase program, effective April 13, 2009. Under the program, the company is authorized to repurchase up to $3 million of its outstanding shares of common stock from time to time, depending on market conditions, share price and other factors. The stock purchases will be made out of available cash in open market transactions at the prevailing market price or through privately negotiated transactions. The duration of the repurchase program is open ended but may be suspended or discontinued at any time in the discretion of the Company's management without prior notice. As of April 13, 2009.
Dialysis Corporation of America Announces Development Of Two New Facilities In Ohio
Dialysis Corporation of America announced the development of two new facilities in Cincinnati, Ohio, through an affiliation with the University of Cincinnati, School of Medicine, to be located in the greater Cincinnati area. The centers will offer equipment and technology, be designed with patient comfort in mind, and include 15 to 18 treatment stations, along with a Peritoneal Suite for patients opting for that modality.
Dialysis Corporation of America Announces Acquisition of Maryland Dialysis Center
Dialysis Corporation of America announced the acquisition of a dialysis center in Hyattsville, Maryland, located at the St. Thomas More Nursing and Rehabilitation Center, where it can treat patients from both within the St. Thomas More Center, as well as the surrounding community. The terms of the acquisition were not disclosed.
Dialysis Corporation of America Announces $25 Million Credit Facility
Dialysis Corporation of America announced that it has amended its secured revolving credit facility with KeyBank National Association to provide for up to $25,000,000 in financing. The three year agreement provides for both base rate and LIBOR loans with interest rates to be based, respectively, upon either the bank's base rate or the London InterBank Offered Rate (LIBOR), plus an applicable margin. The company plans to use its new credit facility to support its continued rapid growth and for general business purposes.
Dialysis Corporation of America Announces The Development Of A New Facility In Pennsylvania
Dialysis Corporation of America announced the development of a new facility in Pennsylvania. The new center, which will be located in Camp Hill and will have a total of twenty four treatment stations.
